Coxsackievirus B3 regulates T-cell infiltration into the heart by lymphocyte function-associated antigen-1 activation via the cAMP/Rap1 axis

被引:11
作者
Shim, Seung-Hyun [1 ]
Kim, Dae-Sun [1 ]
Cho, Whajung [1 ]
Nam, Jae-Hwan [1 ]
机构
[1] Catholic Univ Korea, Dept Biotechnol, Puchon 420743, Gyeonggi Do, South Korea
关键词
B3-INDUCED MYOCARDITIS; SIGNAL-TRANSDUCTION; LFA-1; INFECTION; KINASE; ADHESION; DISEASE; MICE; CONFORMATION; TRANSMISSION;
D O I
10.1099/vir.0.065755-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Coxsackievirus B3 (CVB3) infection can trigger myocarditis and can ultimately lead to dilated cardiomyopathy. It is known that CVB3-induced T-cell infiltration into cardiac tissues is one of the pathological factors causing cardiomyocyte injury by inflammation. However, the underlying mechanism for this remains unclear. We investigated the mechanism of T-cell infiltration by two types of CVB3: the H3 WT strain and the YYFF attenuated strain. T-cell activation was confirmed by changes in the distribution of lymphocyte function-associated antigen-1 (LFA-1). Finally, we identified which viral gene was responsible for LFA-1 activation. CVB3 could infect and activate T-cells in vivo and in vitro, and activated T-cells were detected in CVB3-infected mouse hearts. LFA-1 expressed on the surface of these T-cells had been activated through the cAMP/Rap1 pathway. Recombinant lentiviruses expressing VP2 of CVB3 could also induce LFA-1 activation via an increase in cAMP, whilst VP2 of YYFF did not. These results indicated that CVB3 infection increased cAMP levels and then activated Rap1 in T-cells. In particular, VP2, among the CVB3 proteins, might be critical for this activation. This VP2-cAMP-Rap1-LFA-1 axis could be a potential therapeutic target for treating CVB3-induced myocarditis.
引用
收藏
页码:2010 / 2018
页数:9
相关论文
共 43 条
[11]  
HASHIMOTO I, 1978, BRIT J EXP PATHOL, V59, P13
[12]   Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease [J].
Henke, Andreas ;
Jarasch, Nadine ;
Martin, Ulrike ;
Wegert, Jenny ;
Wildner, Anja ;
Zell, Roland ;
Wutzler, Peter .
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 298 (1-2) :127-134
[13]   LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission [J].
Hioe, CE ;
Chien, PC ;
Lu, CF ;
Springer, TA ;
Wang, XH ;
Bandres, J ;
Tuen, M .
JOURNAL OF VIROLOGY, 2001, 75 (02) :1077-1082
[14]   Vγ4+ T cells promote autoimmune CD8+ cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice:: Role for CD4+ Th1 cells [J].
Huber, SA ;
Sartini, D ;
Exley, M .
JOURNAL OF VIROLOGY, 2002, 76 (21) :10785-10790
[15]   Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase [J].
Katagiri, K ;
Hattori, M ;
Minato, N ;
Irie, S ;
Takatsu, K ;
Kinashi, T .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (06) :1956-1969
[16]   A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3 [J].
Kim, Dae-Sun ;
Park, Jung-Hyun ;
Kim, Joo-Young ;
Kim, DoKeun ;
Nam, Jae-Hwan .
VIRUS GENES, 2012, 44 (02) :176-182
[17]   Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector [J].
Kim, Dae-Sun ;
Cho, Young-Loo ;
Kim, Byoung-Guk ;
Lee, Su-Hae ;
Nam, Jae-Hwan .
VACCINE, 2010, 28 (05) :1234-1240
[18]   Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines [J].
Kim, Dae-Sun ;
Nam, Jae-Hwan .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (02) :179-190
[19]  
Kim J. H., 2013, J BACTERIOL VIROL, V43, P210
[20]   The group B coxsackieviruses and myocarditis [J].
Kim, KS ;
Hufnagel, G ;
Chapman, NM ;
Tracy, S .
REVIEWS IN MEDICAL VIROLOGY, 2001, 11 (06) :355-368